NCT07598903Not yet recruiting
Pharmacy-based Opportunistic Atrial Fibrillation Screening Integrated With Emergency Services (NUMAPLUS-FA)
Pharmacy-based Opportunistic Screening for Atrial Fibrillation Using a Portable ECG Device Integrated With Emergency Medical Services: a Prospective Type-1 Hybrid Implementation Study (NUMAPLUS Project)
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
This study evaluates the feasibility and fidelity of an opportunistic atrial fibrillation (AF) screening programme conducted in 38 community pharmacies in Seville (Spain), using the Kardias® 6-lead portable ECG device, coordinated with the emergency medical services centre Salud Responde (CES 061) and primary care physicians. Eligible participants are individuals aged 65 years or older without a prior AF diagnosis who attend a participating pharmacy for any routine purpose. The screening consists of a 30-second ECG recording performed by a trained community pharmacist. Positive or indeterminate results are transmitted in real time to Salud Responde for clinical validation and referral to primary care. The study is evaluated using the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance). The primary outcome is protocol fidelity, measured by the Implementation Adherence Grade (IAG). The study is part of the NUMAPLUS project, funded by INTERREG VI-A España-Portugal (POCTEP 2021-2027), co-financed by the European Regional Development Fund (ERDF).
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 380 (estimated)
- First submitted
- 7 May 2026
- Start date
- 1 Jun 2026
- Primary completion date
- 15 Dec 2026
- Lead sponsor
- Centro de Emergencias Sanitarias 061 Andalucía
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT07598903
What you commit to
- Study type: Interventional
- Planned participants: 380
- From 1 Jun 2026 to the primary completion date, 15 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Confirmed prior diagnosis of atrial fibrillation
- Concurrent participation in another cardiac rhythm monitoring study
Other
- Implanted pacemaker, implantable cardioverter-defibrillator (ICD) or other intracardiac device
- Clinically evident haemodynamic instability requiring direct emergency 061 activation (active chest pain, severe dyspnoea, syncope)
- Inability to maintain the required position for a 30-second ECG recording
Who the study is looking for
- Age 65 years or older
- Attending a participating community pharmacy for any routine healthcare purpose
- No prior documented or patient-reported diagnosis of atrial fibrillation
- Capacity to provide written informed consent
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centro de Emergencias Sanitarias 061 Coordinator of this site? Confirm its status | Seville | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.